A client who is admitted with an acute coronary syndrome (ACS) receives eptifibatide, a glycoprotein (GP) (IB IIIA. inhibitor. Which assessment finding places the client at greatest risk?

A. Unresponsiveness to painful stimuli indicates a potential neurological issue but does not directly correlate with the risk of bleeding associated with eptifibatide use. B. Hematemesis indicates gastrointestinal bleeding, which is a significant concern in patients on eptifibatide, as it increases the risk of serious bleeding complications. C. Blood in urine (hematuria) can indicate a urinary tract issue or bleeding but is less critical than gastrointestinal bleeding in this context. D. A blood pressure of 100/60 mm Hg may indicate some degree of hypotension but is not as urgent as identifying active bleeding.